These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31561211)

  • 1. Calcitonin induces stem cell-like phenotype in prostate cancer cells.
    Aldahish A; Kale A; Aljameeli A; Shah GV
    Endocr Relat Cancer; 2019 Nov; 26(11):815-828. PubMed ID: 31561211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin Receptor-Zonula Occludens-1 Interaction Is Critical for Calcitonin-Stimulated Prostate Cancer Metastasis.
    Aljameeli A; Thakkar A; Thomas S; Lakshmikanthan V; Iczkowski KA; Shah GV
    PLoS One; 2016; 11(3):e0150090. PubMed ID: 26934365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells.
    Thakkar A; Aljameeli A; Thomas S; Shah GV
    Endocr Relat Cancer; 2016 Jan; 23(1):1-14. PubMed ID: 26432469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin receptor increases invasion of prostate cancer cells by recruiting zonula occludens-1 and promoting PKA-mediated TJ disassembly.
    Aljameeli A; Thakkar A; Shah G
    Cell Signal; 2017 Aug; 36():1-13. PubMed ID: 28428082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways.
    Shah GV; Thomas S; Muralidharan A; Liu Y; Hermonat PL; Williams J; Chaudhary J
    Endocr Relat Cancer; 2008 Dec; 15(4):953-64. PubMed ID: 18784182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: clinical implications and molecular correlates.
    Thakkar A; Bijnsdorp IV; Geldof AA; Shah GV
    Oncol Rep; 2013 Sep; 30(3):1265-74. PubMed ID: 23820954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knock-down of calcitonin receptor expression induces apoptosis and growth arrest of prostate cancer cells.
    Thomas S; Muralidharan A; Shah GV
    Int J Oncol; 2007 Dec; 31(6):1425-37. PubMed ID: 17982669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
    Thomas S; Chiriva-Internati M; Shah GV
    Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
    Huang S; He P; Peng X; Li J; Xu D; Tang Y
    Cell Physiol Biochem; 2015; 37(1):253-68. PubMed ID: 26302893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.
    Thomas S; Chigurupati S; Anbalagan M; Shah G
    Mol Endocrinol; 2006 Aug; 20(8):1894-911. PubMed ID: 16574742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin induces apoptosis resistance in prostate cancer cell lines against cytotoxic drugs via the Akt/survivin pathway.
    Thomas S; Shah G
    Cancer Biol Ther; 2005 Nov; 4(11):1226-33. PubMed ID: 16222118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin is a prostate epithelium-derived growth stimulatory peptide.
    Chien J; Ren Y; Qing Wang Y; Bordelon W; Thompson E; Davis R; Rayford W; Shah G
    Mol Cell Endocrinol; 2001 Jul; 181(1-2):69-79. PubMed ID: 11476942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
    Sabbisetti VS; Chirugupati S; Thomas S; Vaidya KS; Reardon D; Chiriva-Internati M; Iczkowski KA; Shah GV
    Int J Cancer; 2005 Nov; 117(4):551-60. PubMed ID: 15929083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
    Rentala S; Mangamoori LN
    J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion.
    Iczkowski KA; Omara-Opyene AL; Kulkarni TR; Pansara M; Shah GV
    Anticancer Res; 2005; 25(3B):2075-83. PubMed ID: 16158948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
    Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
    Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancer.
    Wang N; Docherty F; Brown HK; Reeves K; Fowles A; Lawson M; Ottewell PD; Holen I; Croucher PI; Eaton CL
    FASEB J; 2015 Aug; 29(8):3141-50. PubMed ID: 25888599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
    Aghajani M; Mokhtarzadeh A; Aghebati-Maleki L; Mansoori B; Mohammadi A; Safaei S; Asadzadeh Z; Hajiasgharzadeh K; Khaze Shahgoli V; Baradaran B
    Mol Biol Rep; 2020 May; 47(5):3691-3703. PubMed ID: 32246247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.